Telus Corp. (NYSE: TU): The Best-Of-Breed For Investing?

Currently, there are 1.47B common shares owned by the public and among those 1.47B shares have been available to trade.

However, the script later moved the day high at 17.56, up 0.31%. The company’s stock has a 5-day price change of 0.95% and -10.40% over the past three months. TU shares are trading -10.40% year to date (YTD), with the 12-month market performance down to -20.74% lower. It has a 12-month low price of $15.47 and touched a high of $21.34 over the same period. TU has an average intraday trading volume of 2.44 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -4.23%, -7.96%, and -9.28% respectively.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Institutional ownership of Telus Corp. (NYSE: TU) shares accounts for 57.39% of the company’s 1.47B shares outstanding.

It has a market capitalization of $23.40B and a beta (3y monthly) value of 0.74. The stock’s trailing 12-month PE ratio is 37.29, while the earnings-per-share (ttm) stands at $0.43. The company has a PEG of 7.04 and a Quick Ratio of 0.62 with the debt-to-equity ratio at 1.70. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.02% over the week and 1.99% over the month.

Earnings per share for the fiscal year are expected to increase by 8.15%, and 15.86% over the next financial year. EPS should grow at an annualized rate of 5.30% over the next five years, compared to -16.12% over the past 5-year period.

TD Securities was of a view on June 17, 2022 that the stock is Buy, while Barclays gave the stock Equal Weight rating on May 10, 2022, issuing a price target of $26. JP Morgan on their part issued Overweight rating on February 14, 2022.

Most Popular

Related Posts